Clinical trialsKlineo raises €2m to speed up access to cancer trialsParis-based Klineo SAS has raised €2M to speed up access to clinical trials for oncology patients using an AI platform.` more ➔
financingLocate Bio Ltd raises £9.2m venture capitalUniversity Nottingham spin out Locate Bio Ltd has added £9.2m venture financing led by Mercia Ventures and Business Growth Fund to its £16.2m raised before. more ➔
BiomanufacturingElectrochaea sells biomethane reactor to Again A/SArchaeal Power-to-biomethan producer Electrochaea GmbH has sold a BioCat bioreactor to the Danish CCU specialist Again A/S. more ➔
financingFlindr Therapeutics BV secures €20m Series A financingOss-based oncology company Flindr Therapeutics BV has secured €20m to advance it first-in-class RNF31 inhibitors, which destabilises E3 ubiquitin ligase. more ➔
bioeconomyNordic Bioproducts Group opens its first production facilityFinnish Nordic Bioproducts Group has opened a production facility to produce advanced cellulosic materials wit the start-up’s AaltoCell technology more ➔
Swiss Biotech DaySwiss Biotech Report reporting record turnoverThe Swiss biotech sector proved robust growth in 2023. Revenues in 2023 increased by CHF500m to CHF7.3bn. Capital investment grew to CHF2bn – just betweeen 2021 (CHF3.4bn) and 2022 (CHF1.3bn). more ➔
Drug DiscoveryIpsen puts US$1.8bn in pipeline expansion in movement disordersIpsen SA and RNA splicing modifier specialist Skyhawk Therapeutics Inc have entered a US$1.8bn licencing option deal in rare neurological disorders. more ➔
AMDSeabelife SAS to develop next-gen dry AMD drugFrench drug maker Seabelife SAS will use a €1.5m price money to develop a new dual-acting necroptosis blocker to reduce cell death in geographic atrophy. more ➔
AmphiStar BVfinancingAmphiStar BV secures €6m to expand productionWaste based biosurfactants producer Amphistar BV has closed a €6m funding round led by the European Circular Bioeconomy Fund (ECBF), Qbic III and Flanders Future Tech Fund (FFTF). more ➔
HIVNaobios and Sumagen partner to develop HIV vaccineVaccine maker Sumagen Co. Ltd has launched a cGMP manufacturing partnership with French Naobios SAS for clinical testing of Sumagen’s inactivated HIV vaccine candidate. more ➔
AmphiStar BV
